Wird geladen...

Sodium–glucose cotransporter 2 inhibitor‐associated diabetic ketoacidosis in patients with type 1 diabetes: Metabolic imbalance as an underlying mechanism

For type 1 diabetes patients with inadequate glycemic control, one treatment option is to increase the insulin dose (scenario 1), which should not give rise to a “metabolic imbalance.” A second option is additional treatment with a sodium–glucose cotransporter 2 inhibitor, which might lead to a “met...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Diabetes Investig
Hauptverfasser: Ogawa, Wataru, Hirota, Yushi
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2019
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6627165/
https://ncbi.nlm.nih.gov/pubmed/30768861
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.13026
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!